Kitoxan®
home > Kitoxan®
Kitoxan® by Latoxan
The first natural library of venom fractions for Drug Discovery and High Throughput Screening (HTS).
Kitoxan Kitoxan V01 Kitoxan V02 Kitoxan V03 Kitoxan V04
<< Back to Kitoxan V02

Search : `Vipera palaestinae` - PubMed Results: 66
  1. Serum Cholesterol Concentration on Admission in 415 Dogs Envenomated by Daboia (Vipera) palaestinae as a Marker of Envenomation Severity and Outcome-A Retrospective Study.
    Klainbart S, Kelmer E, Beeri-Cohen I, Keinan Y, Segev G, Aroch I
    Toxins (Basel) 2023 Oct 12;15(10) PMID:37888640 PubMed - indexed for MEDLINE

  2. Severity of a Vipera palaestinae envenomation objective findings associated with a complicated hospitalization course following a Vipera palaestinae bite.
    Koter N, Gat T, Furth M, Sadeh R, Galante O, Tomer O, Klein S, Muszkat M, Fuchs L, Nachshon A
    Toxicon 2023 Oct;234:107304 PMID:37778739 PubMed - indexed for MEDLINE

  3. Clinical Characteristics and Management of Snake Bite Injuries in the Jerusalem Area.
    Gross I, Maree A, Rekhtman D, Mujahed W, Hashavya S, Assaf J
    J Clin Med 2023 Jun 19;12(12) PMID:37373825 PubMed

  4. Is severity of Daboia (Vipera) palaestinae snakebites influenced by season of exposure?
    Agajany N, Kozer E, Agajany N, Trotzky D, Kishk IA, Youngster I
    Toxicon 2022 Jan 30;206:51-54 PMID:34954132 PubMed - indexed for MEDLINE

  5. Assessment of Knowledge about First Aid Methods, Diagnosis, and Management of Snakebite among Nursing Students: A Cross-Sectional Study from Palestine.
    Kharusha IK, Sulaiman SS, Samara AM, Al-Jabi SW, Zyoud SH
    Emerg Med Int 2020;2020:8815632 PMID:33381318 PubMed

  6. Efficacy of specific antivenom and fresh frozen plasma in reversing Daboia palaestinae venom-induced hemostatic derangement.
    Nivy R, Aroch I, Bruchim Y
    J Vet Emerg Crit Care (San Antonio) 2020 Jul;30(4):396-404 PMID:32589364 PubMed - indexed for MEDLINE

  7. An assessment of medical students' proficiency in the diagnosis and management of snakebites: a cross-sectional study from Palestine.
    Sulaiman SS, Kharusha IK, Samara AM, Al-Jabi SW, Zyoud SH
    J Occup Med Toxicol 2020;15:3 PMID:32099576 PubMed

  8. Toxicity of Vipera palaestinae venom and antagonistic effects of methanolic leaf extract of Eryngium creticum lam.
    Nusair SD, Ahmad MI
    Toxicon 2019 Aug;166:1-8 PMID:31095960 PubMed - indexed for MEDLINE

  9. Daboia (Vipera) palaestinae Envenomation in 123 Horses: Treatment and Efficacy of Antivenom Administration.
    Tirosh-Levy S, Solomovich-Manor R, Comte J, Nissan I, Sutton GA, Gabay A, Gazit E, Steinman A
    Toxins (Basel) 2019 Mar 19;11(3) PMID:30893807 PubMed - indexed for MEDLINE

  10. Vipers of the Middle East: A Rich Source of Bioactive Molecules.
    Rima M, Alavi Naini SM, Karam M, Sadek R, Sabatier JM, Fajloun Z
    Molecules 2018 Oct 22;23(10) PMID:30360399 PubMed - indexed for MEDLINE

  11. Daboia (Vipera) palaestinae envenomation in horses: Clinical and hematological signs, risk factors for mortality and construction of a novel severity scoring system.
    Tirosh-Levy S, Solomovich R, Comte J, Sutton GA, Steinman A
    Toxicon 2017 Oct;137:58-64 PMID:28698056 PubMed - indexed for MEDLINE

  12. Evaluation of antivenom therapy for Vipera palaestinae bites in children: experience of two large, tertiary care pediatric hospitals.
    Pivko-Levy D, Munchnak I, Rimon A, Balla U, Scolnik D, Hoyte C, Voliovitch Y, Glatstein M
    Clin Toxicol (Phila) 2017 Apr;55(4):235-240 PMID:28103732 PubMed - indexed for MEDLINE

  13. A retrospective evaluation of Vipera palaestinae envenomation in 18 cats: (2006-2011).
    Lenchner I, Aroch I, Segev G, Kelmer E, Bruchim Y
    J Vet Emerg Crit Care (San Antonio) 2014 Jul-Aug;24(4):437-43 PMID:25154358 PubMed - indexed for MEDLINE

  14. Protein C activity in dogs envenomed by Vipera palaestinae.
    Hadar G, Kelmer E, Segev G, Bruchim Y, Aroch I
    Toxicon 2014 Sep;87:38-44 PMID:24905649 PubMed - indexed for MEDLINE

  15. Identification of ?2?1 integrin inhibitor VP-i with anti-platelet properties in the venom of Vipera palaestinae.
    Arlinghaus FT, Momic T, Ammar NA, Shai E, Spectre G, Varon D, Marcinkiewicz C, Heide H, Lazarovici P, Eble JA
    Toxicon 2013 Mar 15;64:96-105 PMID:23319078 PubMed - indexed for MEDLINE

  16. Neutralization of Vipera and Macrovipera venoms by two experimental polyvalent antisera: a study of paraspecificity.
    Archundia IG, de Roodt AR, Ramos-Cerrillo B, Chippaux JP, Olguín-Pérez L, Alagón A, Stock RP
    Toxicon 2011 Jun;57(7-8):1049-56 PMID:21530569 PubMed - indexed for MEDLINE

  17. Pediatric poisonings in Israel: National Poison Center data.
    Bentur Y, Obchinikov ND, Cahana A, Kovler N, Bloom-Krasik A, Lavon O, Gurevych B, Lurie Y
    Isr Med Assoc J 2010 Sep;12(9):554-9 PMID:21287800 PubMed - indexed for MEDLINE

  18. Haemostatic abnormalities and clinical findings in Vipera palaestinae-envenomed dogs.
    Aroch I, Yas-Natan E, Kuzi S, Segev G
    Vet J 2010 Aug;185(2):180-7 PMID:19560952 PubMed - indexed for MEDLINE

  19. Vipera palaestinae bite and serum sickness during pregnancy.
    Lurie Y, Bentur Y
    J Emerg Med 2010 Jun;38(5):e67-70 PMID:19327939 PubMed - indexed for MEDLINE

  20. "Cardiac arrhythmias and serum cardiac troponins in Vipera palaestinae envenomations in dogs".
    Segev G
    J Vet Intern Med 2008 Jul-Aug;22(4):825; author reply 825 PMID:18647151 PubMed - indexed for MEDLINE

  21. Cardiac arrhythmias and serum cardiac troponins in Vipera palaestinae envenomation in dogs.
    Segev G, Ohad DG, Shipov A, Kass PH, Aroch I
    J Vet Intern Med 2008 Jan-Feb;22(1):106-13 PMID:18289296 PubMed - indexed for MEDLINE

  22. Molecular phylogeny of Vipera Laurenti, 1768 and the related genera Macrovipera (Reuss, 1927) and Daboia (Gray, 1842), with comments about neurotoxic Vipera aspis aspis populations.
    Garrigues T, Dauga C, Ferquel E, Choumet V, Failloux AB
    Mol Phylogenet Evol 2005 Apr;35(1):35-47 PMID:15737580 PubMed - indexed for MEDLINE

  23. Fatal Vipera xanthina palestinae envenomation in 16 dogs.
    Aroch I, Segev G, Klement E, Shipov A, Harrus S
    Vet Hum Toxicol 2004 Oct;46(5):268-72 PMID:15487652 PubMed - indexed for MEDLINE

  24. Evaluation of antivenom therapy in Vipera palaestinae bites.
    Bentur Y, Raikhlin-Eisenkraft B, Galperin M
    Toxicon 2004 Jul;44(1):53-7 PMID:15225562 PubMed - indexed for MEDLINE

  25. Vipera palaestinae envenomation-induced bradycardia.
    Blum A, Tatur I, Simsolo C
    Eur J Intern Med 2004 Apr;15(2):134 PMID:15172031 PubMed - as supplied by publisher

  26. Vipera palaestinae envenomation in 327 dogs: a retrospective cohort study and analysis of risk factors for mortality.
    Segev G, Shipov A, Klement E, Harrus S, Kass P, Aroch I
    Toxicon 2004 May;43(6):691-9 PMID:15109890 PubMed - indexed for MEDLINE

  27. Unusual local complications of Vipera palaestinae bite.
    Bentur Y, Cahana A
    Toxicon 2003 Apr;41(5):633-5 PMID:12676442 PubMed - indexed for MEDLINE

  28. Snakebite poisoning in children--a call for unified clinical guidelines.
    Ben Abraham R, Winkler E, Eshel G, Barzilay Z, Paret G
    Eur J Emerg Med 2001 Sep;8(3):189-92 PMID:11587463 PubMed - indexed for MEDLINE

  29. Evolutionary relationships among the true vipers (Reptilia: Viperidae) inferred from mitochondrial DNA sequences.
    Lenk P, Kalyabina S, Wink M, Joger U
    Mol Phylogenet Evol 2001 Apr;19(1):94-104 PMID:11286494 PubMed - indexed for MEDLINE

  30. Sarcocystis infections among snakes in Israel.
    Paperna I, Finkelman S
    Parassitologia 1998 Dec;40(4):447-56 PMID:10645557 PubMed - indexed for MEDLINE

  31. Suspected Vipera palaestinae envenomation in three cats.
    Bentur Y, Raikhlin B
    Vet Hum Toxicol 1999 Dec;41(6):406-7 PMID:10592956 PubMed - indexed for MEDLINE

  32. Vipera palaestinae antivenin.
    Moroz C
    Public Health Rev 1998;26(3):233-6 PMID:10444960 PubMed - indexed for MEDLINE

  33. Venomous snakes of Israel: ecology and snakebite.
    Kochva E
    Public Health Rev 1998;26(3):209-32 PMID:10444959 PubMed - indexed for MEDLINE

  34. Suspected Vipera palaestinae envenomation in three cats.
    Michal MT, Eran L
    Vet Hum Toxicol 1999 Jun;41(3):145-8 PMID:10349702 PubMed - indexed for MEDLINE

  35. Positive Darwinian selection in Vipera palaestinae phospholipase A2 genes is unexpectedly limited to the third exon.
    Kordis D, Bdolah A, Gubensek F
    Biochem Biophys Res Commun 1998 Oct 20;251(2):613-9 PMID:9792822 PubMed - indexed for MEDLINE

  36. The Bov-B lines found in Vipera ammodytes toxic PLA2 genes are widespread in snake genomes.
    Kordis D, Gubensek F
    Toxicon 1998 Nov;36(11):1585-90 PMID:9792174 PubMed - indexed for MEDLINE

  37. Preliminary evaluation of Vipera palaestinae snake bite treatment in accordance to the severity of the clinical syndrome.
    Shemesh IY, Kristal C, Langerman L, Bourvin A
    Toxicon 1998 Jun;36(6):867-73 PMID:9663693 PubMed - indexed for MEDLINE

  38. Vipera palaestinae snake envenomations: experience in children.
    Paret G, Ben-Abraham R, Ezra D, Shrem D, Eshel G, Vardi A, Winkler E, Barzilay Z
    Hum Exp Toxicol 1997 Nov;16(11):683-7 PMID:9426372 PubMed - indexed for MEDLINE

  39. Bov-B long interspersed repeated DNA (LINE) sequences are present in Vipera ammodytes phospholipase A2 genes and in genomes of Viperidae snakes.
    Kordis D, Gubensek F
    Eur J Biochem 1997 Jun 15;246(3):772-9 PMID:9219538 PubMed - indexed for MEDLINE

  40. Delayed administration of Vipera xanthina palaestinae antivenin.
    Bentur Y, Zveibel F, Adler M, Raikhlin B
    J Toxicol Clin Toxicol 1997;35(3):257-61 PMID:9140319 PubMed - indexed for MEDLINE

  41. Protein and cDNA structures of an acidic phospholipase A2, the enzymatic part of an unusual, two-component toxin from Vipera palaestinae.
    Krizaj I, Bdolah A, Gubensek F, Bencina P, Pungercar J
    Biochem Biophys Res Commun 1996 Oct 14;227(2):374-9 PMID:8878523 PubMed - indexed for MEDLINE

  42. Early generation merogonies of Sarcocystis muriviperae in liver and muscles of white mice.
    Paperna I, Finkelman S
    Folia Parasitol (Praha) 1996;43(2):91-9 PMID:8768459 PubMed - indexed for MEDLINE

  43. Ultrastructural study of Sarcocystis muriviperae development in the intestine of its snake hosts.
    Paperna I, Finkelman S
    Folia Parasitol (Praha) 1996;43(1):13-9 PMID:8682406 PubMed - indexed for MEDLINE

  44. Myocarditis following envenoming with Vipera palaestinae in two horses.
    Hoffman A, Levi O, Orgad U, Nyska A
    Toxicon 1993 Dec;31(12):1623-8 PMID:8146876 PubMed - indexed for MEDLINE

  45. Decreased serum cholesterol level after snake bite (Vipera palaestinae) as a marker of severity of envenomation.
    Winkler E, Chovers M, Almog S, Pri-Chen S, Rotenberg M, Tirosh M, Ezra D, Halkin H
    J Lab Clin Med 1993 Jun;121(6):774-8 PMID:8505588 PubMed - indexed for MEDLINE

  46. Natural anti-snake venom proteins.
    Domont GB, Perales J, Moussatché H
    Toxicon 1991;29(10):1183-94 PMID:1801313 PubMed - indexed for MEDLINE

  47. Isolation and characterization of a hemorrhagic factor from the venom of the snake Atractaspis engaddensis (Atractaspididae).
    Ovadia M
    Toxicon 1987;25(6):621-30 PMID:3114916 PubMed - indexed for MEDLINE

  48. Experimental transmission of Sarcocystis muriviperae n. sp. to laboratory mice by sporocysts from the Palestinian viper (Vipera palaestinae): a light and electron microscope study.
    Matuschka FR, Heydorn AO, Mehlhorn H, Abd-Al-Aal Z, Diesing L, Biehler A
    Parasitol Res 1987;73(1):33-40 PMID:3101062 PubMed - indexed for MEDLINE

  49. Isolation and characterization of a proteolytic factor from the venom of Vipera palaestinae.
    Nakar O, Ovadia M, Kochva E
    Toxicon 1986;24(3):293-304 PMID:3520957 PubMed - indexed for MEDLINE

  50. Lethal potencies and immunoelectrophoretic profiles of venoms and Vipera bornmulleri and Vipera latifii.
    Weinstein SA, Minton SA
    Toxicon 1984;22(4):625-9 PMID:6474499 PubMed - indexed for MEDLINE
For Research Purposes Only - Not for Human Use

Privacy Statement | Ordering Informations | www.latoxan.com | www.biotoxan.com
Natural Active Ingredients - Venoms - Toxins - Alkaloids - Plant Compounds - Ion Channel & Receptor Ligands
LATOXAN SAS - Z.A. les Auréats, 845 Avenue Pierre Brossolette - 26800 PORTES-lès-VALENCE - France - Phone +33 475 419 191 - Fax +33 475 419 199 - www.latoxan.com
Optimised for Mozilla FireFox & Google Chrome (not for IE) - Copyright © Latoxan 2010
Last update : 2024-04-29 11:22:01